The Share & Transparency

Share and ownership information

AdderaCare AB (publ) shares are traded on Nasdaq First North Growth MarketThe share name is abbreviated to ADDERA and the ISIN code is SE0009160922. The first trading day was 1 December 2016.

List of shareholdings and shareholders as of 30-06-2021:

NameNumber of sharesShare of votes and capital
Linc AB8 212 50024,36 %
Bengt Olsson genom bolag*2 881 1618,55 %
Hans Andersson genom bolag och privat**2 395 0327,10 %
Jan Kvarnström***2 346 7506,96 %
Sannaskogen AB****2 331 8986,92%
Tass AB2 000 0005,93%
Other13 549 49441,37%
Total33 716 835100,00 %

*Bengt Olsson owns 100% of Prosus Capital AB and 100% of Prosus AB. Olsson was a board member of the Parent Company until 2016-09-28. Olsson has been a board member of the Parent Company since 2020-05-27.

**Hans Andersson has been a board member of the Parent Company since 2019-05-23 and Chairman of the Board of the Parent Company since 2020-05-27.

***Jan Kvarnström was a board member of the Parent Company until 2019-05-23.

****Bo Thorvinger owns 100% in Sannaskogen AB. Thorvinger was a board member of the parent company until 2016-09-28.

Board, number of shares: 

Hans Andersson2 395 032
Bengt Olsson2 881 161
Sofie Redzamatovic0
Sanna Lindberg0
Charlotte Stjerngren0

Management, number of shares:

Marianne Sernevi (CEO)19 019
Henrik Carlsson (CFO)62 875

Transparency

For transactions carried out by persons in leading positions within AdderaCare AB, see: https://marknadssok.fi.se/publiceringsklient.

Presentations and presentation materials

CEO Marianne Sernevi gives a presentation about AdderaCare at Erik Penser Bolagsdagen (November 2020).

CEO Marianne Sernevi is interviewed about AdderaCare (November 2020).

Previous CEO Michael Hermansson on the finances, listing and acquisition strategy going forward.

Previous CEO Michael Hermansson and previous Chairman of the Board Per Nilsson on AdderaCare.

Investment strategy & Financial goals

Investment strategy

We buy profitable, well-run companies that after the acquisition are allowed to continue operating as before and to keep their names, their culture and their management. Our well-thought-out and tried-and-tested process provides the acquisition procedure with structure and guarantees quality in the acquisitions that are made.

Our seven criteria for acquisition:

  • Positive cash flow
  • Profitable (operating profit EBITDA)
  • Majority of sales from own products/service
  • Most sales within the home care/accessibility aids sector
  • Company located in Nordic region
  • Seller prepared to sell the majority of the company
  • Not active within assistance

Financial goals

AdderaCare’s long-term goal is to create a corporate group that is financially profitable and demonstrates organic growth that is faster than that of the market.

AdderaCare’s goals:

  • During the build-up phase, to have sales growth of 30-50%
  • Profit margin above 10% over one economic cycle
  • Indebtedness must not be more than three times the operating profit (EBITDA)
  • Equity/assets ratio over 35%
  • Undertake a list change to Nasdaq Nordic Small Cap 2019-2020

Financial calendar

2020

27 februari
Year-end Report

14 maj
Interim Report Q1

27 maj
Annual General Meeting

21 augusti
Half-yearly Report

19 november
Interim Report Q3

2021

25 february
Year-end Report

5 may
Annual Report 2020

12 may
Interim Report Q2

26 may
Annual General Meeting

26 august
Half-yearly Report

11 november
Interim Report Q3

Articles of Association

AdderaCare’s Articles of Association are available to read in PDF format below (in Swedish):

AdderaCare bolagsordning pdf

Auditor & Certified Adviser (CA)

Auditor

KPMG

KPMG
David Olow

Certified Adviser (CA)

Svensk Kapitalmarknadsgranskning AB
Email: ca@skmg.se
Phone: +46 11 32 30 732

Subscribe